Metabolic & GLP-1
Tirzepatide
Dual GIP and GLP-1 receptor agonist studied for metabolic parameters.
Purity: > 99%Reference: CAS 2023788-19-2
from 115,99 €
Strength / size
115,99 €
Ships within 2 weeks · Available to order
For laboratory research use only. Not for human consumption.
Description
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Research has explored its impact on metabolic parameters, including measures of body composition and energy balance, in controlled study environments.
For laboratory research purposes only. Not for human or veterinary use.
Specifications
- 10 mgTIRZEPATIDE-10MG
- 115,99 €
Related peptides
★Ships within 2 weeksSemaglutide
> 99%GLP-1 receptor agonist studied for glycemic control and body-weight endpoints.
from 59,99 €
★Ships within 48 hoursRetatrutide
> 99%Triple agonist acting on GIP, GLP-1 and glucagon receptors.
from 115,99 €
Ships within 2 weeksAOD-9604
> 99%Modified hGH C-terminal fragment studied for lipolytic pathways.
from 24,99 €